Partners in Discovery

Vanderbilt-Ingram Cancer Center

Vanderbilt-Ingram Cancer Center is at the forefront of new discoveries that help us prevent, find, treat, manage and cure cancer. But we can't make these discoveries alone. Our patients, caregivers, community leaders, donors, volunteers, and educators contribute their insight, time, and passion to advancing the discoveries that lead us closer to a cure.

No matter how cancer has touched your life, you are a key partner in our efforts to save lives and improve the quality of life for those with cancer.

_{Harnessing the power of

science for our patients}

_{Our doctors and researchers are turning today's}
_{scientific discoveries into tomorrow's treatments.}
_{Learn more about our research programs and initiatives.}

Research Programs

Specialized Programs of Research Excellence (SPOREs)

Research Centers & Initiatives

Proven Track Record

A leader in research, innovation and treatment. We are one of 53 National Cancer Institute-designated Comprehensive Cancer Centers, dedicated to an integrated and patient-focused approach.

Patients, Partners, Progress

Our patients and families are our most important partners in discovery – and the motivation behind our efforts to advance research and improve cancer care.

Read their stories from Momentum magazine.

We’ve Only Just Begun

Facing cancer with youthful resilience

Pay it Forward

Bladder cancer research fund honors mentor

Blazing a new trail

Clinical trial participant forges a different treatment path

Holowatyj named chair of scientific advisory board for ACPMP Research Foundation

Andreana Holowatyj, PhD, MSCI, has been named the inaugural chair of the scientific advisory board for the Appendix Cancer Pseudomyxoma Peritonei Research Foundation.

VIGH, VICC establish cancer research program in Zambia

VUMC and the University of Zambia are partnering on a program to develop a cadre of researchers and educators to lead cancer epidemiology research and training in Zambia and to encourage U.S.-based researchers to engage in cancer research in low- and middle-income countries.